Skip to main content
OpenTrials
Completed

NCT Number: NCT01418469

Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD

Studies on resting human muscle show that ingestion of the branched-chain amino acids (BCAA): leucine, valine and isoleucine have an anabolic effect on muscle protein metabolism. However, the effects of BCAA intake on protein metabolism during exercise are less clear. When BCAA were supplied as single amino acids, without other amino acids and/or carbohydrates, no effects were observed on protein kinetics. On the other hand, ingestion of BCAA during running appeared to reduce the catabolic effect of running on muscle protein metabolism. These experiments were all performed with mixtures of the BCAA with or without carbohydrates but not in the form of complete meals with food protein as a basis. Therefore, it is still unknown whether a protein meal, containing a substantial amount of BCAA is beneficial during exercise by inducing an anabolic effect.

Whey and Casein protein contain a substantial amount of BCAA in contrast to Soy protein. Therefore, it is hypothesized that milk-based proteins are a better and more physiological source of BCAA during exercise and will lead to more protein anabolism. Most of the available studies have been carried out in young and fit humans but there are hardly any data are available in the increasing population of the elderly. Therefore it is still unknown whether a BCAA rich protein meal can enhance the anabolic effect of exercise in older individuals.

Besides sarcopenia, a substantial part of the elderly is suffering from a chronic systemic disease such as chronic obstructive pulmonary disease (COPD). COPD represents an important health care problem. COPD is the fourth leading cause of death and will be the third leading cause worldwide in 2020. Besides the local impairment, COPD is a chronic wasting disease, associated with alterations in intermediary metabolism. Substantial disturbances have been found in BCAA (and related) metabolism in these patients at rest and during exercise. It might therefore be of clinical relevance to study the metabolic effects of BCAA rich protein meals in patients with COPD at rest and during exercise.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Maastricht UMC

Maastricht, Netherlands

About this study

In this study we investigate whether milk based protein sources of BCAA (casein and whey proteins) are superior to soy protein in the stimulation of protein anabolism before, during and after cycle exercise in COPD and healthy elderly and young subjects, and whether adding BCAA to soy protein will increase protein anabolism in these subjects.

To investigate Leucine, Isoleucine and Valine metabolism during and after exercise in COPD and healthy subjects

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Irreversible chronic airflow limitation (FEV1 <70% of predicted)
  • Clinically stable condition

Exclusion criteria

  • Oxygen supplementation
  • Respiratory tract infection or exacerbation of his disease at least 4 weeks prior to the study
  • Oral corticosteroids as maintenance medication
  • Other concomitant metabolic disease (ie malignancy, cardiac failure, recent surgery, severe endocrine, hepatic or renal disorder)

Treatment and study plan

Caseinate

Dietary Supplement

18 mg protein/kg body weight caseinate and 46 mg maltodextrin / kg body weight per 20 min sip feeding

Other names: casein

Whey protein isolate

Dietary Supplement

18 mg protein/kg body weight whey protein isolate and 46 mg maltodextrin / kg body weight per 20 min sip feeding

Other names: Whey

Soy

Dietary Supplement

18 mg protein/kg body weight soy and 46 mg maltodextrin / kg body weight per 20 min sip feeding

soy+BCAA

Dietary Supplement

18 mg protein/kg body weight soy+BCAA and 46 mg maltodextrin / kg body weight per 20 min sip feeding

Primary outcomes

  1. Change in Net whole body protein synthesis

    Time frame: 6 hours

    Net whole body protein synthesis during protein feeding and the response to a 20 min cycle exercise bout

Secondary outcomes

  1. Change in whole body protein synthesis rate

    Time frame: 6 hours

    Whole body protein synthesis rate during protein feeding and the response to 20 min cycle exercise bout

  2. Change in Leucine turnover

    Time frame: 6 hours

    Leucine turnover during protein feeding and the response to a 20 min cycle exercise bout

  3. Change in Isoleucine turnover

    Time frame: 6 hours

    Isoleucine turnover during protein feeding and the response to a 20 min cycle exercise bout

  4. Change in Valine turnover

    Time frame: 6 hours

    Valine turnover during protein feeding and the response to a 20 min cycle exercise bout

  5. Change in plasma lactate concentration

    Time frame: 6 hours

    Plasma lactate during protein feeding and the response to a 20 min cycle exercise bout

  6. Change in NH3 concentration

    Time frame: 6 hours

    Plasma NH3 during protein feeding and the response to a 20 min cycle exercise bout

  7. Change in plasma amino acids concentrations

    Time frame: 6 hours

    Plasma amino acid concentrations during protein feeding and the response to a 20 min cycle exercise bout

  8. Splanchnic extraction of amino acids during protein feeding

    Time frame: 6 hours

    Splanchnic extraction of amino acids during protein feeding and the response to a 20 min cycle exercise bout

  9. Change in whole body protein breakdown rate

    Time frame: 6 hours

    Whole body protein breakdown rate during protein feeding and the response to cycle exercise

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Collaborators

  • European Dairy Association (EDA), Brussels

Registry information

Official study title

The Effects of Exercise on the Metabolic Fate of Branched Chain Amino Acids in Relation to Aging and Chronic Disease.

Important dates

Study start
2002
Primary completion
2003
Study completion
2004
First posted
Aug 17, 2011
Registry last updated
Aug 17, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.